دورية أكاديمية
Quadruplet regimen for newly diagnosed multiple myeloma is effective in the standard-risk subgroup but not in the high-risk subgroup
| العنوان: | Quadruplet regimen for newly diagnosed multiple myeloma is effective in the standard-risk subgroup but not in the high-risk subgroup |
|---|---|
| المؤلفون: | Jianghua Ding, Shengping Gong |
| المصدر: | Frontiers in Pharmacology, Vol 15 (2024) |
| بيانات النشر: | Frontiers Media S.A., 2024. |
| سنة النشر: | 2024 |
| المجموعة: | LCC:Therapeutics. Pharmacology |
| مصطلحات موضوعية: | quadruplet regimen, newly-diagnosed, multiple myeloma, standard risk, high risk, Therapeutics. Pharmacology, RM1-950 |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 1663-9812 |
| العلاقة: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1398879/fullTest; https://doaj.org/toc/1663-9812Test |
| DOI: | 10.3389/fphar.2024.1398879 |
| الوصول الحر: | https://doaj.org/article/1224ecc4e3ad4f689992c19b5f4dcdc4Test |
| رقم الانضمام: | edsdoj.1224ecc4e3ad4f689992c19b5f4dcdc4 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 16639812 |
|---|---|
| DOI: | 10.3389/fphar.2024.1398879 |